5 Worst Performing Biotech Stocks in 2023
Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE) develops treatments for neurological diseases such as schizophrenia. Cerevel Therapeutics Holdings, Inc.
Apellis Pharmaceuticals Inc. (APLS)
Market is closed
News
- First
- << Previous
- 21 - 30
- Next >>
5 Oversold MidCap Stocks To Buy
In this piece, we will take a look at five oversold midcap stocks to buy.
Wall Street Analysts Are Downgrading These 5 Stocks
On August 1, Argus analyst John Eade adjusted his perspective on Canadian National Railway Company (NYSE:CNI), as the company's revenue growth outlook is anticipated to present challenges in the coming...
Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) Q2 2023 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to Apellis Pharmaceuticals Second Quarter 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode.
5 Oversold NASDAQ Stocks to Buy
San Francisco, California-based Vir Biotechnology, Inc. (NASDAQ:VIR) is a commercial-stage immunology company focused on the development of therapies to treat and prevent serious infectious diseases.
15 Worst Performing NASDAQ Stocks In 2023
In this article, we discuss 15 worst performing NASDAQ stocks in 2023.
12 Stocks with Biggest Upside Potential According to Analysts
In this article, we will take a look at the 12 stocks with biggest upside potential according to analysts.
5 Stock Market Forecasts Next 6 Months
Australian stocks also suffered the same fate in 20222, coming under immense pressure as the Reserve Bank of Australia embarked on an aggressive monetary policy tightening.
5 Gene Editing Stocks With the Best Long-Term Potential
In this article, we will take a look at the 5 gene editing stocks with the best long-term potential.
- First
- << Previous
- 21 - 30
- Next >>
Billionaire Hedge Funds
